• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. LIFESPAN EPTFE VASCULAR GRAFT; VASCULAR GRAFT PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. LIFESPAN EPTFE VASCULAR GRAFT; VASCULAR GRAFT PROSTHESIS Back to Search Results
Model Number R06050CS
Device Problem Complete Blockage (1094)
Patient Problem Embolus (1830)
Event Date 05/15/2020
Event Type  Injury  
Manufacturer Narrative
We have received the complaint device for evaluation.However, we were unable to confirm the reported defect with the graft during our evaluation process.Graft was implanted in the patient's arm for av access on (b)(6) 2020.On (b)(6) 2020, surgeon observed a blood clot in the graft during an ultrasound scan.Graft was then explanted on (b)(6) 2020 and was replaced with another lifespan eptfe vascular graft.The occlusion occurred prior to any cannulation for av access.There was no injury to the patient as the result of this incident.Our review of the lot history records for this lot did not find any discrepancies either in the manufacturing or packaging process that could be related to this incident.Further, we have not received any other complaints of a similar nature for devices from this lot.Our ifu properly warns users about the risks which may occur in conjunction with the use of any vascular prosthesis including thrombosis.As stated in the ifu, complications due to individual patient reaction to an implanted device, or to physical or chemical changes in the components, may necessitate reoperation and replacement (sometimes within hours or days) of the prosthetic device.Careful and continuous medical follow-up is advised so that prosthesis-related complications can be diagnosed and properly managed to minimize danger to the patient.
 
Event Description
This graft (r06050cs/lvg2327) was implanted in the patient's arm on (b)(6).It was confirmed by echo that there was a part where blood flow was blocked in the lumen of this graft on (b)(6).The surgery was performed to exchange this graft to another graft (r06050cs/unknown lot number) on (b)(6).After the surgery, the patient is fine and no health damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESPAN EPTFE VASCULAR GRAFT
Type of Device
VASCULAR GRAFT PROSTHESIS
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington, ma
Manufacturer (Section G)
LEMAITRE VASCULAR, INC.
63 second ave
burlington, ma
Manufacturer Contact
pragya thikey
63 second ave
burlington, ma 
2212266152
MDR Report Key10200407
MDR Text Key198322407
Report Number1220948-2020-00068
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00840663105243
UDI-Public00840663105243
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K872090
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/26/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberR06050CS
Device Catalogue NumberR06050CS
Device Lot NumberLVG2327
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/05/2020
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/27/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/14/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-